IGFBP2 and breast carcinoma: Recently, IGFBP2 has been identified as a potential and valuable biomarker in malignancies including breast cancer [15], ovarian cancer [16], colorectal cancer [17, 18], glioblastoma [19], lung cancer [20, 21], prostate cancer [22], and gastric cancer [25].